Navigation Links
Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
Date:2/21/2008

based on serology tests for HBV surface antigen and core antibodies. Based on discussions with the FDA, Gen-Probe and Chiron agreed to conduct a post-marketing study of the PROCLEIX ULTRIO assay to demonstrate the HBV yield required for a donor-screening claim.

Gen-Probe began this post-marketing study in early 2007. To date, approximately 500,000 blood donations have been screened in the study, and two HBV yield cases have been identified. Data on these two yield cases comprise the foundation of the Company's supplemental BLA.

HBV is the most common serious liver infection in the world and is transmitted through contact with blood and body fluids. HBV infection can lead to liver failure, cirrhosis or cancer. According to the World Health Organization, more than 350 million people worldwide are chronically infected with HBV. More than one million people die annually as a result of HBV infections.

Trademarks

PROCLEIX and ULTRIO are trademarks of Novartis Vaccines and Diagnostics, Inc. TIGRIS is a trademark of Gen-Probe.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about Gen-Probe's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
2. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
3. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
8. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
9. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
10. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
11. EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... ROSEVILLE, Minn. , Sept. 17, 2014  Rebiotix Inc. ... of the company,s lead product candidate, RBX2660 (microbiota suspension) will ... the IDWeek 2014 conference in Philadelphia ... will be presented during the poster session on Thursday, October ... C. difficile Infection: 60-Day Interim Analysis of the ...
(Date:9/17/2014)... DALLAS , Sept. 17, 2014   OTEMR, ... 2014 Edition Complete EHR certification, which designates that the ... the Stage 1 and Stage 2 Meaningful Use measures ... and Reinvestment Act (ARRA).  ONETOUCH EMR 2.0 was certified ... an Office of the National Coordinator-Authorized Certification Body (ONC-ACB) ...
(Date:9/17/2014)... of people suffer from neck and arm pain as a ... FDA approved the launch of a clinical trial for the ... Spinal Kinetics, which may offer relief to people with cervical ... for Special Surgery (HSS), the number one orthopedic hospital in ... York City and in the Northeast participating in ...
Breaking Medicine Technology:PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
(Date:9/17/2014)... Thompson HealthDay Reporter ... the womb to household chemicals known as phthalates might ... University researchers reported in a new study. Children ... asthma between age 5 and 11 if their mothers ... phthalates (pronounced thal-ates), the researchers found. The two phthalates ...
(Date:9/17/2014)... R.I. [Brown University] As Congress adjourns this month ... senators will step over on their way out the ... Repeal and Medicare Provider Payment Modernization Act of 2014. ... Surgery , Dr. Eli Adashi recounts what he and ... bipartisan bill. The perennial trouble with how Medicare pays ...
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... 2014 StartX , a nonprofit ... raising rounds of funding at its Summer Demo Day ... and media, was the first such gathering held at ... the university. The presentations were delivered on an expansive ... Labs, a 2,000 square foot life science facility that ...
(Date:9/17/2014)... 17, 2014 The in vitro diagnostics ... technology market, focusing on molecular diagnostics for conditions such ... genetic testing. The IVD market value is projected to ... of 2017. The major drivers of the market’s growth ... which is evidenced by the explosion for raid and ...
Breaking Medicine News(10 mins):Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
... Simon J. ... NJHCFFA. , ... --Simon J. Samaha, M.D., recently was confirmed by the New Jersey State Senate as one of ... (The Authority). , , , , ,Dr. Samaha is the President and Chief Executive Officer of ...
... Perkins Warns Houston "Abortion Super Center" Will Be Prototype ... Jan. 18 An estimated 10,000 people converged on ... across from the nation,s largest abortion facility.  Tony Perkins, president of ... Call to Conscience in Houston today to rally pro-life ...
... to ask simple question of male patients , MONDAY, ... strong warning sign that a man might be at ... problems, a long-running study indicates. , "We saw that ... men with erectile function still had a 40 percent ...
... experts stress that ,senior moments, don,t guarantee that dementia ... News) -- Mental lapses among older adults occur more ... new research finds. , Excessive daytime sleepiness, staring into ... fluctuations that often precede Alzheimer,s, say researchers from Washington ...
... 18 An urgent aid shipment containing 4,000 tents and ... Haitian coastal town of Jacmel. , Jacmel, 30 miles southwest of ... devastated by the recent earthquake with more than 350 people reported ... that 60 percent of buildings were damaged or destroyed. , An ...
... to Run in Honor of People With Cystic Fibrosis , ... Fibrosis Foundation,s most active volunteers will carry the Olympic Torch today in ... Opening Ceremony of the 2010 Olympic Winter Games. , Liz Burns ... than $600,000 for CF research, care and education programs. She is ...
Cached Medicine News:Health News:Simon J. Samaha, M.D., Appointed Public Member of New Jersey Health Care Facilities Financing Authority 2Health News:FRC's Tony Perkins Speaks to Rally of Ten Thousand Across from Nation's Largest Abortion Facility 2Health News:Erectile Dysfunction Predicts Heart Disease 2Health News:Frequent Mental Lapses May Precede Alzheimer's 2Health News:Frequent Mental Lapses May Precede Alzheimer's 3Health News:Haiti: Lifesaving Aid Makes Its Way Through to Quake-Hit Jacmel by Ship 2Health News:Cystic Fibrosis Foundation Volunteer to Carry Torch for Vancouver 2010 Olympic Winter Games 2
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... MK-2000 Keratome System provides ... wide range of applications. ... ultra-sharp stainless steel disposable ... sterile and ready to ...
Medicine Products: